Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-04

Clinical Trial Update: Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by the University of California, San Diego tested brain-penetrating HIV drugs in China to prevent cognitive impairment in peo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Diego | Conditions: HIV Infections, Central Nervous System Diseases | Phase 4 | Status: COMPLETED